Psychoactive Medication Use in Pediatric Heart Transplant Recipients: An Assessment of Prevalence, Risk Factors, and Outcomes
Pediatric Transplantation · 2026
DOI: 10.1111/petr.70272 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Transplantation, 2026. Verfasst von Jenna Schauer und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Cardiology, Department of Pediatrics, Columbia University Irving Medical Center, New York-Presbyterian Morgan Stanley Children'…. Hauptthemen laut MEDLINE: Heart Transplantation, Psychotropic Drugs. Die Arbeit nennt 26 Literaturangaben. Gefördert von: Pediatric Heart Transplant Society, Enduring Hearts.
Abstract (Originalsprache)
Background
There is increasing recognition of the mental health toll of heart transplant on pediatric transplant patients and their families. Little is known about the use of psychoactive medications in this population.
Methods
The Pediatric Heart Transplant Society (PHTS) collects data on patients pre and post‐transplant including medication use for anxiety, depression, and attention deficit/hyperactivity disorder. We analyzed psychoactive medication use among transplant recipients older than 5 years at follow‐up and assessed for associations with pre‐transplant risk factors and post‐transplant outcomes. A survey about mental health resources was sent to all PHTS sites.
Results
Among 1792 patients older than 5 years at 1 year post transplant, 301 patients (16.8%) were prescribed at least one psychoactive medication, 246 (13.7%) were prescribed antianxiety/antidepressant medications, and 59 (3.3%) were prescribed medications for ADHD. Patients on psychoactive medications at 1 year post transplant tended to be older and more sick at the time of transplant. There was no association between psychoactive medication use on graft loss, coronary artery disease, or rejection at 1‐year post‐transplant; there was a higher incidence of coronary artery disease at 3 years post transplant and increased coronary artery disease and graft loss at 5 years post transplant. Screening instrument usage varied across sites. Mental health providers are typically available for patients but vary with regard to timing and disciplines involved across centers.
Conclusions
A significant proportion of pediatric heart transplant recipients take psychoactive medications. Psychoactive medication usage is associated with worse long‐term outcomes including graft loss and coronary artery disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pediatric Cardiology, Department of Pediatrics, Columbia University Irving Medical Center, New York-Presbyterian Morgan Stanley Children's Hospital, New York, New York, USA.
- Division of Pediatric Cardiology, Department of Pediatrics, Benioff Children's Hospital, University of California-San Francisco, San Francisco, California, USA.
- Kirklin Solutions, Inc., Birmingham, Alabama, USA.
- Division of Pediatric Cardiology, Department of Pediatrics, University of Virginia Children's Hospital, Charlottesville, Virginia, USA.
- Division of Pediatric Cardiology, Department of Pediatrics, Baylor College of Medicine, Texas Children's Hospital, Houston, Texas, USA.
- Division of Pediatric Cardiology, Department of Pediatrics, Johns Hopkins Hospital, Bloomberg Children's Center, Blalock-Taussig-Thomas Heart Center, Baltimore, Maryland, USA.
ORCID-Profile: Jenna Schauer, Othman A Aljohani, Firezer Haregu, Micah S Brosbe
Förderung
- Pediatric Heart Transplant Society
- Enduring Hearts
Zitieren
APA
Schauer, J., Aljohani, O. A., Cantor, R., Fraser, A., Haregu, F., Hope, K., Kirklin, J. K., Thompson, C., Urschel, S., Zaim, N., Zhao, H., & Brosbe, M. S. (2026). Psychoactive Medication Use in Pediatric Heart Transplant Recipients: An Assessment of Prevalence, Risk Factors, and Outcomes. Pediatric Transplantation. https://doi.org/10.1111/petr.70272
Vancouver
Schauer J, Aljohani OA, Cantor R, Fraser A, Haregu F, Hope K, et al. Psychoactive Medication Use in Pediatric Heart Transplant Recipients: An Assessment of Prevalence, Risk Factors, and Outcomes. Pediatric Transplantation. 2026. doi:10.1111/petr.70272
BibTeX
@article{Schauer2026,
author = {Schauer, Jenna and Aljohani, Othman A and Cantor, Ryan and Fraser, Anna and Haregu, Firezer and Hope, Kyle and Kirklin, James K and Thompson, Consuela and Urschel, Simon and Zaim, Nadia and Zhao, Hong and Brosbe, Micah S},
title = {Psychoactive Medication Use in Pediatric Heart Transplant Recipients: An Assessment of Prevalence, Risk Factors, and Outcomes},
journal = {Pediatric Transplantation},
year = {2026},
doi = {10.1111/petr.70272}
}
EUVIMED